Objective: To analyze the role of acetylsalicylic acid (ASA) in immunomodulation of me-senchymal stem cells derived from gingiva (GMSCs), and to explore the role of ASA in enhancing the immumomodulation of GMSCs and the capacity of GMSCs to treat immune disorders and the underlying mechanism. Methods: Flow cytometry analysis were used to analyze the role of ASA in the expression of stem cells surface markers CD146, CD105, CD90, CD34 and CD45 in GMSCs,and the GMSCs proliferation was analyzed by 5-bromo-2-deoxyuridine (BrdU) staining and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The GMSCs and T cells co-culture system was established to analyze the role of ASA in immunomodulation of GMSCs by measuring T cell apoptosis using flow cytometry analysis and inflammatory cytokines using enzyme linked immunosorbent assay (ELISA). Further more, the dextran sulfate sodium (DSS) induced colitis mouse model was established and the mouse body weight, disease activity score, histological index and pathological change of colons were analyzed after GMSC infusion. Results: The proliferation of GMSCs and the expressions of CD105, CD146 in GMSCs were increased after ASA treatment. In the GMSCs and T cells co-culture system, GMSCs induced T cells apoptosis and inhibited interferon γ (IFN-γ) and tumor necrosis factor α (TNF-α) secretion by T cells, which were enhanced by ASA treatment. In vivo, GMSCs infusion could ameliorate DSS-induced colitis, including inhibited DSS-induced mouse body weight loss, decreased disease activity score and histological index, and decreased inflammation cells infiltration in colons, as shown by hematoxylin-eosin (HE) staining. Moreover, the therapeutic effects of GMSC infusion on DSS-induced colitis could be enhanced by ASA treatment. Mechanically, ASA treatment increased FasL expression of Fas/FasL death pathway in GMSCs to induce T cells apoptosis. Conclusion: ASA enhanced immunomodulation of GMSCs and increased the capacity of GMSCs to ameliorate DSS-induced colitis in mice.
YANG Rui-li
,
YU Ting-ting
,
ZHOU Yan-heng
. Acetylsalicylic acid treatment enhanced immunomodulatory function of mesenchymal stem cells derived from gingiva[J]. Journal of Peking University(Health Sciences), 2017
, 49(5)
: 872
-877
.
DOI: 10.3969/j.issn.1671-167X.2017.05.023
[1] Zhang Q, Shi S, Liu Y, et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis [J]. J Immunol, 2009, 4(11): 7787-7798.
[2] 杜令倩,杨丕山, 葛少华. 人牙龈干细胞的分离鉴定及基质细胞衍生因子-1对其趋化效应的研究 [J]. 华西口腔医学杂志,2016, 3(33): 238-241.
[3] Yamaza T, Miura Y, Bi Y, et al. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents [J]. PLoS One, 2008, 3(7): e2615.
[4] Liu Y, Wang L, Kikuiri T, et al.Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha [J]. Nat Med, 2011, 17(12): 1594-1601.
[5] Chen C, Akiyama K, Yamaza T, et al. Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression [J]. EMBO Mol Med, 2014, 6(3): 322-334.
[6] Liu Y, Chen C, Liu, S et al. Acetylsalicylic acid treatment improves differentiation and immunomodulation of SHED [J]. J Dent Res, 2015, 94 (1): 209-218.
[7] Chapple IL, Van der Weijden F, Doerfer C, et al. Primary prevention of periodontitis: managing gingivitis[J]. J Clin Periodontol, 2015, 42(Suppl. 16): 71-76.
[8] Xu X, Chen C, Akiyama K, et al. Gingivae contain neural-crest-and mesoderm-derived mesenchymal stem cells[J]. J Dent Res, 2013, 92(9): 825-832.
[9] Sun L, Akiyama K, Zhang H, et al. Mesenchymal stem cell transplantation reverses multi-organ dysfunction in systemic lupus erythematosus mice and humans[J]. Stem Cells, 2009, 27(6):1421-1432.
[10] Svobodova E, Krulova M, Zajicova A, et al. The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population[J]. Stem Cells Dev, 2012, 21(6): 901-910.
[11] Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses[J]. Blood, 2005, 105(4):1815-1822.
